Prestige Clinical Research Report issue

For profit Phase 2 Phase 3
Founded: Franklin OH United States (2009)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT01887418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

testosterone (delatestryl) (2 trials)

Drugs in Phase 2 Trials (1)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypogonadism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2